Cargando…
Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice
Berberine (BBR) shows very low plasma levels after oral administration due to its poor absorption by the gastrointestinal tract. We have previously demonstrated that BBR showed increased gastrointestinal absorption and enhanced antidiabetic effects in db/db mice after being entrapped into solid lipi...
Autores principales: | Xue, Mei, Zhang, Liang, Yang, Ming-xing, Zhang, Wei, Li, Xiu-min, Ou, Zhi-min, Li, Zhi-peng, Liu, Su-huan, Li, Xue-jun, Yang, Shu-yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531046/ https://www.ncbi.nlm.nih.gov/pubmed/26346310 http://dx.doi.org/10.2147/IJN.S84565 |
Ejemplares similares
-
Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles
por: Xue, Mei, et al.
Publicado: (2013) -
Inhibition of Aldose Reductase Activates Hepatic Peroxisome Proliferator-Activated Receptor-α and Ameliorates Hepatosteatosis in Diabetic db/db Mice
por: Qiu, Longxin, et al.
Publicado: (2012) -
Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice
por: Li, Meng, et al.
Publicado: (2019) -
Mibefradil reduces blood glucose concentration in db/db mice
por: Lu, Yujie, et al.
Publicado: (2014) -
Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA(2)β/Cardiolipin/Opa1 pathway in db/db mice and in Palmitate-treated MIN6 β-cells
por: Li, Junnan, et al.
Publicado: (2019)